Abstract
BACKGROUND. We determined whether treatment of metastatic prostate cancer cells with doxorubicin (DOX) and interferon-alpha (IFN-α) prevented the emergence of highly undifferentiated tumor cells. METHODS. The state of cell differentiation was determined by analysis of prostate-specific antigen (PSA), E-cadherin, keratin, and vimentin. RESULTS. Human prostate cancer LNCaP-LN3 cells growing in culture as multicell spheroids expressed higher levels of E-cadherin and E-cadherin-associated β-catenin than LNCaP-LN3 cells growing as monolayers. Treatment of cells with DOX downregulated PSA, E-cadherin, and keratin, and upregulated expression of vimentin and vascular endothelial growth factor (VEGF) mRNA. While treatment of cells with IFN-α did not alter gene expression, the addition of IFN-α to cultures treated with DOX produced synergistic toxicity and abrogated the changes in gene expression observed in cells treated with DOX alone. CONCLUSIONS. Treatment with IFN-α and DOX should be further explored as a therapeutic strategy for androgen-insensitive prostate cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 19-29 |
Number of pages | 11 |
Journal | Prostate |
Volume | 49 |
Issue number | 1 |
DOIs | |
State | Published - Sep 15 2001 |
Keywords
- Apoptosis
- Cell dedifferentiation
- Doxorubicin
- Interferon-alpha
- Prostate cancer
ASJC Scopus subject areas
- Oncology
- Urology